V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20015137 | 20158298 | 1.73 | 80 | null | 2022-02-25 | 2022-05-15 | Topotecan (intravenous) | null | N | TOPOTECAN | 100216967 |
| 20015188 | 20158299 | 1.69 | 67.2 | Palliative (P) | 2019-12-19 | 2019-12-19 | EC | 02 | N | NAB-PACLITAXEL | 101757171 |
| 20018993 | 20158302 | 1.75 | 95 | null | 2021-07-19 | 2021-07-23 | Etoposide + Ifosfamide (5 days) | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101406014 |
| 20021080 | 20158303 | 1.32 | 61.1 | Palliative (P) | 2019-08-02 | 2020-01-03 | OSIMERTINIB | 02 | null | GEMCITABINE + PACLITAXEL | 100564750 |
| 20022615 | 20158304 | 1.83 | 76.5 | null | 2018-06-07 | 2018-09-15 | CHOP R | 02 | null | CISPLATIN + TEYSUNO | 101570575 |
| 20032659 | 20158307 | 1.77 | 47 | Palliative (P) | 2018-08-09 | 2018-08-09 | Capecitabine + Streptozocin | 02 | Y | BCG | 101629700 |
| 20033541 | 20158309 | 1.95 | 61.7 | null | 2017-02-15 | 2017-04-24 | BCG Intravesical | 02 | null | TEMOZOLOMIDE | 101695090 |
| 20034897 | 20158311 | 1.8 | 64 | null | 2019-01-28 | 2019-01-31 | COSMIC TRIAL | 02 | null | SCOPE2 TRIAL | 100677716 |
| 20035688 | 20158312 | 1.45 | 63.9 | 03 | 2018-04-25 | 2018-12-09 | Bortezomib + MELPHALAN | N | null | DOXORUBICIN | 100982369 |
| 20037775 | 20158314 | 1.89 | null | Palliative (P) | 2015-06-19 | 2018-12-23 | Fluorouracil + Folinic + RT Bossett | 2 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101017543 |
| 20039364 | 20158315 | 1.72 | 107.7 | null | 2020-12-16 | 2021-01-04 | Doxorubicin 75mg/m2 | null | N | CARBO + FLUOROURACIL | 101090148 |
| 20039412 | 20158316 | 1.69 | 76 | Palliative (P) | 2017-06-03 | 2018-10-13 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101347751 |
| 20039998 | 20158317 | 1.77 | 68.5 | Curative (C) | 2017-06-10 | 2019-04-01 | PACLITAXEL + TRASTUZUMAB | Y | null | CAPE + OXALIPLATIN + TRASTUZUMAB | 101839329 |
| 20040304 | 20158318 | 1.56 | 69.8 | Adjuvant (A) | 2020-09-30 | 2020-10-01 | IBRUTINIB | N | N | ECF | 100597632 |
| 20040612 | 20158319 | 1.65 | 44.4 | Palliative (P) | 2017-12-16 | 2018-02-08 | Cytarabine Low Dose | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 101227502 |
| 20044417 | 20158320 | 1.55 | 52 | Palliative (P) | 2019-11-16 | 2019-11-24 | POLEM TRIAL | 02 | null | GEMCITABINE + OXALIPLATIN | 101641616 |
| 20046134 | 20158321 | 1.8 | 59.8 | null | 2017-12-17 | 2018-02-06 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | null | ARISTOTLE TRIAL | 100443890 |
| 20046135 | 20158322 | 1.97 | 53.1 | Palliative (P) | 2022-05-18 | 2022-05-18 | null | N | N | BORTEZOMIB | 100166988 |
| 20048379 | 20158323 | 1.55 | 69.1 | null | null | null | Topotecan (oral) | N | null | TCX | 101181261 |
| 20048721 | 20158324 | 1.91 | 79.5 | null | 2017-05-17 | 2017-11-28 | IRINOTECAN + MDG + PANITUMUMAB | 01 | null | COSMIC TRIAL | 101266698 |
| 20049050 | 20158325 | 1.51 | 74.7 | null | 2021-08-13 | 2021-08-14 | GemCarbo Days 1+8 | 02 | null | IPILIMUMAB + NIVOLUMAB | 101167184 |
| 20049933 | 20158326 | 1.77 | null | null | 2018-05-11 | 2018-06-11 | Bevacizumab + FLUOROURACIL + IRINOTECAN | 02 | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 100460285 |
| 20051858 | 20158327 | 1.9 | 88 | null | 2017-09-24 | 2017-09-25 | TOPOTECAN | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 101811196 |
| 20051949 | 20158328 | 1.51 | 67 | Curative (C) | null | 2021-08-07 | CARBOPLATIN + FLUOROURACIL + Trastuzumab | 02 | null | EOF | 100930921 |
| 20054258 | 20158329 | 1.8 | 56.2 | Palliative (P) | 2021-05-30 | 2021-06-10 | POMALIDOMIDE | 02 | Y | PALBOCICLIB | 101133641 |
| 20054283 | 20158330 | 1.6 | 65 | Curative (C) | 2017-01-21 | 2017-01-21 | Fluorouracil + Folinic + RT Bossett | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100040411 |
| 20058058 | 20158331 | 0 | null | null | 2019-09-01 | 2019-09-14 | Gemcitabine + Oxaliplatin | 02 | null | ATEZOLIZUMAB | 100370115 |
| 20058995 | 20158333 | 1.86 | 58 | null | 2021-03-05 | 2021-04-07 | Binimetinib + Encorafenib | 02 | N | RIPRETINIB | 100995173 |
| 20060754 | 20158334 | 1.79 | 15.5 | Palliative (P) | 2019-10-21 | 2020-02-28 | ECF | 01 | N | AZACITIDINE | 101781127 |
| 20062395 | 20158335 | 1.8 | 55.05 | 03 | 2019-08-09 | 2019-08-26 | Ipilimumab | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100680052 |
| 20062437 | 20158336 | 1.57 | 74.4 | Palliative (P) | null | 2017-05-25 | Hepatoblastoma Relapse VI | N | N | GEMCITABINE + OXALIPLATIN | 101004426 |
| 20062756 | 20158337 | 1.8 | 51.15 | null | 2020-03-16 | 2020-06-10 | CAM-PLEX Trial | 01 | null | BUSULFAN | 100793430 |
| 20064678 | 20158338 | 1.79 | 88.2 | Neo-adjuvant (N) | 2017-03-12 | 2017-04-02 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | TEMOZOLOMIDE | 101019356 |
| 20065210 | 20158339 | 1.55 | 12.4 | Palliative (P) | 2019-03-05 | 2019-04-18 | Carboplatin + Pemetrexed | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100023013 |
| 20065293 | 20158340 | 1.72 | 58 | 03 | 2019-12-27 | 2020-01-20 | PHITT B or C Cisplatin | 02 | N | CAP + RT | 100738854 |
| 20065775 | 20158341 | 1.71 | 63.7 | null | 2018-12-05 | 2019-01-19 | MITOMYCIN | 02 | null | DARATUMUMAB | 101764724 |
| 20073243 | 20158343 | 1.58 | 62.9 | Curative (C) | 2020-05-03 | 2021-03-24 | CAV | 02 | N | ACELARATE TRIAL | 100198859 |
| 20084150 | 20158344 | null | null | Palliative (P) | 2018-07-05 | 2018-07-18 | CISPLATIN + FLUOROURACIL + Trastuzumab | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 100861511 |
| 20092444 | 20158345 | 1.57 | 98.8 | Palliative (P) | 2017-05-26 | 2017-06-03 | DARATUMUMAB | 02 | N | MELPHALAN | 100058981 |
| 20094036 | 20158346 | 1.8 | 88.8 | Palliative (P) | 2019-09-14 | 2019-09-18 | SCOPE 2 TRIAL | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101473769 |
| 20101840 | 20158347 | 1.54 | 59 | null | 2018-09-09 | 2018-09-16 | ECF | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100678107 |
| 20104742 | 20158348 | 1.6 | 78 | null | 2021-10-19 | 2021-11-04 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | CAPE + OXALIPLATIN + TRASTUZUMAB | 101354924 |
| 20106539 | 20158349 | 1.6 | 65 | null | 2021-10-03 | 2022-05-30 | CAPECITABINE + OXALIPLATIN + Trastuzumab | 01 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100578527 |
| 20107276 | 20158350 | 1.77 | 41.8 | Palliative (P) | 2019-06-07 | 2019-07-28 | TRASTUZUMAB EMTANSINE | 02 | N | LOMUSTINE | 100470913 |
| 20112612 | 20158351 | 1.83 | 56.8 | null | 2018-07-05 | 2018-07-24 | Venetoclax | 02 | N | MELPHALAN | 101479073 |
| 20112952 | 20158352 | 1.87 | 76 | Palliative (P) | 2018-06-18 | 2018-07-05 | BCG Intravesical | 02 | null | BACILLUS CALMETTE-GUERIN | 101726390 |
| 20116918 | 20158353 | 1.81 | 59.1 | Adjuvant (A) | 2019-02-28 | 2019-05-22 | STAMPEDE TRIAL | 02 | N | PRIMUS 002 TRIAL | 100663476 |
| 20124933 | 20158355 | 1.61 | 93.6 | null | 2018-10-31 | 2018-12-03 | Paclitaxel albumin (Abraxane) 7 day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101624058 |
| 20133725 | 20158358 | 1.83 | 50 | null | 2019-02-18 | 2019-03-07 | Hydroxycarbamide | 02 | null | CISPLATIN + TEYSUNO | 101658038 |
| 20145785 | 20158360 | 1.65 | 79.3 | Curative (C) | 2021-05-22 | 2021-07-26 | null | 02 | null | BORTEZOMIB | 101457750 |